Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$365,940
+$9,270 QoQ
Shares Held
2,335
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,029
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 38%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OAKWORTH CAPITAL, INC. holds $21,742,030 across 13 Drug Manufacturers - General names. NVS ranks #10 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,682 | $5,615,730 | |
| 2 | MRK |
Merck & Co., Inc.
|
37,177 | $4,777,244 | |
| 3 | JNJ |
Johnson & Johnson
|
18,417 | $4,677,363 | |
| 4 | ABBV |
AbbVie Inc.
|
12,650 | $3,183,244 | |
| 5 | AZN |
Astrazeneca PLC
|
4,201 | $796,593 | |
| 6 | AMGN |
Amgen Inc
|
2,008 | $727,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
10,513 | $605,758 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,689 | $592,407 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,940 | 2,335 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $356,670 | 2,335 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $338,470 | 2,455 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $285,590 | 2,227 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $280,622 | 2,319 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $258,522 | 2,319 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $225,661 | 2,319 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $266,731 | 2,319 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $339,607 | 3,190 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $367,767 | 3,802 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $384,493 | 3,808 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $388,392 | 3,813 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $391,934 | 3,884 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $361,928 | 3,934 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $377,485 | 4,161 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $316,277 | 4,161 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $356,801 | 4,221 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $370,392 | 4,221 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $395,451 | 4,521 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $369,727 | 4,521 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $412,496 | 4,521 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $386,455 | 4,521 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $429,089 | 4,544 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $404,277 | 4,649 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $396,872 | 4,544 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $391,884 | 4,753 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||